Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy
Natalia V Danilova,1,2 Zhomart R Kalzhanov,3 Nina A Nefedova,2 Pavel G Mal’kov,2 Ioannis P Kosmas,1,4 Marina Y Eliseeva,1,5 Ospan A Mynbaev1,5,6 1International Translational Medicine and Biomodeling Research Team, MIPT Center for Human Physiology, Laboratory of Cellular and Mole...
Guardado en:
Autores principales: | Danilova NV, Kalzhanov ZR, Nefedova NA, Mal’kov PG, Kosmas IP, Eliseeva MY, Mynbaev OA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cf9e39db1804671afb81be4c984915b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Challenging nanoparticles: a target of personalized adhesion prevention strategy
por: Mynbaev OA, et al.
Publicado: (2014) -
Inhibition of oxygen scavengers realized by peritoneal macrophages: an adhesion prevention target?
por: Mynbaev OA, et al.
Publicado: (2014) -
Safety and effectiveness of dose-sparing strategies for intramuscular seasonal influenza vaccine: a rapid scoping review
por: Jesmin Antony, et al.
Publicado: (2021) -
Vascular Damage in the Aorta of Wild-Type Mice Exposed to Ionizing Radiation: Sparing and Enhancing Effects of Dose Protraction
por: Nobuyuki Hamada, et al.
Publicado: (2021) -
Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity
por: Yuan Q, et al.
Publicado: (2014)